SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-17-006156
Filing Date
2017-11-02
Accepted
2017-11-02 16:22:48
Documents
16
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 20-F s107891_20f.htm 20-F 2799515
2 EXHIBIT 8.1 s107891_ex8-1.htm EX-8.1 1481
3 EXHIBIT 12.1 s107891_ex12-1.htm EX-12.1 9140
4 EXHIBIT 12.2 s107891_ex12-2.htm EX-12.2 8957
5 EXHIBIT 13.1 s107891_ex13-1.htm EX-13.1 4408
6 EXHIBIT 13.2 s107891_ex13-2.htm EX-13.2 4305
7 EXHIBIT 15.1 s107891_ex15-1.htm EX-15.1 3311
8 GRAPHIC img001_v1.jpg GRAPHIC 20169
9 GRAPHIC img002_v1.jpg GRAPHIC 44146
10 GRAPHIC img003_v1.jpg GRAPHIC 25801
11 GRAPHIC img004_v1.jpg GRAPHIC 69987
12 GRAPHIC img005_v1.jpg GRAPHIC 13171
13 GRAPHIC img006_v1.jpg GRAPHIC 11918
14 GRAPHIC img007_v1.jpg GRAPHIC 11801
15 GRAPHIC img008_v1.jpg GRAPHIC 21362
16 GRAPHIC img009_v1.jpg GRAPHIC 467
  Complete submission text file 0001615774-17-006156.txt   3134700
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 001-38104 | Film No.: 171172705
SIC: 2834 Pharmaceutical Preparations